Schedule of procedures testing the applicability and safety of using self-capillary blood collection. حسب Harika Dasari (18145735)

الموضوعات:

Characteristics of participants. حسب Harika Dasari (18145735)

الموضوعات:

Feedback from participants on training, satisfaction and preference with the capillary sampling device. حسب Harika Dasari (18145735)

الموضوعات:

The significantly enriched KEGG pathway from the DEPs. حسب Guohua Ji (436621)

The significant prognostic value of CpG in KGs. حسب Alvira Ajadee (19762306)

الموضوعات:

Significant GO terms enriched based on the DEGs in control vs. noise groups. حسب Guangwei Ma (8503014)

Significant GO terms enriched based on the DEGs in control vs. noise groups. حسب Guangwei Ma (8503014)

Significant KEGG pathways enriched based on the DEGs in control vs. noise groups. حسب Guangwei Ma (8503014)

Patient demographic information at four time points. حسب Ruitian Song (11045127)

الموضوعات:

Mitochondrial fusion event (see Fig 7A). حسب Cynthia Alsayyah (18452506)

Mitochondrial fission event (see Fig 7B). حسب Cynthia Alsayyah (18452506)

MS decreases the larger amplitude distribution in adult rats. حسب Jesús David Ayala-Rodríguez (17364296)

الموضوعات:

Attitude errors caused by constant bias of gyroscopes. حسب Wei Sun (93580)

Attitude errors caused by scale factors of gyroscopes. حسب Wei Sun (93580)

Summary of the earliest time point for significant WD-induced changes in NASH-associated markers. حسب Melinda H. Spooner (6551933)

"…The figure illustrates the earliest time point for a significant change in the marker abundance and whether the marker <b>Increased</b> or <b>Decreased</b> in response to the WD. …"

FTA card stabilization of YFV RNA decrease at high temperature. حسب Emily H. Davis (12878086)

Association of SHR and the risk of all-cause mortality. حسب Heshan Cao (17967095)

الموضوعات:

Significant differences between Th17-cell levels of dogs suffering from IVDH at all three sampling time points and in comparison with the healthy control group. حسب Annika Kämpe (11507012)

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

DHA decreased cell viability in HepG3 cells. حسب Arlet Hernandez (12289155)